0000897069-23-001062.txt : 20230802 0000897069-23-001062.hdr.sgml : 20230802 20230802175823 ACCESSION NUMBER: 0000897069-23-001062 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230802 FILED AS OF DATE: 20230802 DATE AS OF CHANGE: 20230802 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kroenig Bradley CENTRAL INDEX KEY: 0001985521 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41765 FILM NUMBER: 231137318 MAIL ADDRESS: STREET 1: C/O MIRA PHARMACEUTICALS, INC. STREET 2: 900 WEST PLATT STREET, SUITE 200 CITY: TAMPA STATE: FL ZIP: 33606-2173 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MIRA PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001904286 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 853354547 STATE OF INCORPORATION: FL BUSINESS ADDRESS: STREET 1: 855 N WOLFE STREET #623-6 CITY: BALTIMORE STATE: MD ZIP: 21205 BUSINESS PHONE: 813-369-5150 MAIL ADDRESS: STREET 1: 324 SOUTH HYDE PARK AVENUE, SUITE 350 CITY: TAMPA STATE: FL ZIP: 33606 FORMER COMPANY: FORMER CONFORMED NAME: Mira1a Therapeutics, Inc. DATE OF NAME CHANGE: 20220112 3 1 form3.xml X0206 3 2023-08-02 0 0001904286 MIRA PHARMACEUTICALS, INC. MIRA 0001985521 Kroenig Bradley C/O MIRA PHARMACEUTICALS, INC. 900 WEST PLATT STREET, SUITE 200 TAMPA FL 33606-2173 true Common Stock 50000 D Stock Option (right to buy) 5 2032-06-15 Common Stock 30000 D Stock Option (right to buy) 5 2033-04-28 Common Stock 10000 D The option vested and became exercisable as to 23,334 shares on June 15, 2022 and 3,333 shares on June 15, 2023. 3,333 shares will become exercisable on June 15, 2024. The option vested and became exercisable in full on April 28, 2023. /s/ Michelle Yanez, Attorney-in-Fact for Bradley Kroenig 2023-08-02 EX-24.1 2 kroenigpoa.htm
POWER OF ATTORNEY
The undersigned as a Section 16 reporting person of MIRA Pharmaceuticals, Inc. (the “Company”), hereby constitutes and appoints Michelle Yanez, Erez Aminov, and Christos Nicholoudis, signing singly, the undersigned’s true and lawful attorney‑in‑fact to:
(1)  execute, deliver and file for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director of  the Company, Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder (the “Exchange Act”);
(2)  do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority;
(3)  seek or obtain, as the undersigned’s representative and on the undersigned’s behalf, information on transactions in the Company’s securities from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such information to the undersigned and approves and ratifies any such release of information; and
(4)  take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney‑in‑fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney‑in‑fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney‑in‑fact may approve in such attorney‑in‑fact’s discretion.
 
The undersigned hereby grants to each such attorney‑in‑fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney‑in‑fact, or such attorney‑in‑fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.  The undersigned acknowledges that the foregoing attorneys‑in‑fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Exchange Act.  The undersigned further acknowledges and agrees that the attorney-in-fact and the Company are relying on written and oral information provided by the undersigned to complete such forms and the undersigned is responsible for reviewing the completed forms prior to their filing.  The attorney-in-fact and the Company are not responsible for any errors or omissions in such filings.  The attorney-in-fact and the Company are not responsible for determining whether or not the transactions reported could be matched with any other transactions for the purpose of determining liability for short-swing profits under Section 16(b).
This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the Company and the foregoing attorneys‑in‑fact.
[Signature page follows.]
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this July 31, 2023.
 
 /s/ Bradley Kroenig             
Name:  Bradley Kroenig